COMMUNIQUÉ DE PRESSE publié le 21/03/2024 à 07:00, il y a 2 années 7 mois Announcement on the payment of the cash distribution from the capital reduction of STRABAG SE (ISIN AT000000STR1) resolved on 16 June 2023 via a value right (ISIN AT0000A36HK3) STRABAG SE announces payment of cash distribution from capital reduction resolved on 16 June 2023 via value right (ISIN AT0000A36HK3). Shareholders to receive EUR 9.05 per share on 26 March 2024 Shareholders STRABAG SE Capital Reduction Cash Distribution Value Right
BRÈVE publiée le 20/02/2024 à 10:00, il y a 2 années 8 mois STRABAG SE annonce une augmentation de capital non monétaire pour mars 2024 Augmentation De Capital STRABAG SE Rasperia Trading Limited Marché Autrichien Droit Des Sociétés
BRÈVE publiée le 20/02/2024 à 10:00, il y a 2 années 8 mois STRABAG SE Announces Non-Monetary Capital Increase for March 2024 Capital Increase STRABAG SE Rasperia Trading Limited Austrian Market Corporate Law
COMMUNIQUÉ DE PRESSE publié le 20/02/2024 à 10:00, il y a 2 années 8 mois STRABAG SE: entry of non-cash capital increase in the commercial register planned for 21 March 2024 STRABAG SE plans non-cash capital increase to reduce MKAO's shareholding. Implementation on 21 March 2024 aims to reduce stake below 25% Shareholding STRABAG SE Non-cash Capital Increase MKAO Capital Reduction
COMMUNIQUÉ DE PRESSE publié le 15/02/2024 à 07:00, il y a 2 années 9 mois STRABAG SE: new record output volume, EBIT margin expected to approach 5% STRABAG SE reports new record output volume of €19.1 billion (+8% vs. 2022) and anticipates EBIT margin approaching 5%. Positive growth in key markets contributed to the record figure Financial Results Construction Industry EBIT Margin STRABAG SE Output Volume
COMMUNIQUÉ DE PRESSE publié le 06/02/2024 à 12:01, il y a 2 années 9 mois EQS-Adhoc: STRABAG SE expects EBIT margin close to 5 % for 2023 STRABAG SE expects EBIT margin close to 5 % for 2023 financial year and output volume to reach around € 19 billion, following an internal evaluation 2023 Financial Year EBIT Margin Earnings STRABAG SE Output Volume
COMMUNIQUÉ DE PRESSE publié le 02/10/2023 à 08:00, il y a 3 années 1 mois STRABAG SE: Share-based option was chosen for 88% of eligible shares
COMMUNIQUÉ DE PRESSE publié le 11/09/2023 à 08:02, il y a 3 années 2 mois STRABAG SE: Details concerning the implementation of resolved capital measures
COMMUNIQUÉ DE PRESSE publié le 31/08/2023 à 07:00, il y a 3 années 2 mois STRABAG SE: Higher earnings despite challenging market environment
COMMUNIQUÉ DE PRESSE publié le 16/06/2023 à 13:30, il y a 3 années 5 mois STRABAG SE: All agenda items of 19th Annual General Meeting approved, Strategy 2030 presented
Publié le 17/11/2026 à 18:00, il y a 6 heures 19 minutes 20261117 - Accor - Accor to increase its stake in Ennismore
Publié le 17/11/2026 à 18:00, il y a 6 heures 19 minutes Accor - Accor se renforce au capital de Ennismore
Publié le 17/11/2026 à 17:45, il y a 6 heures 34 minutes EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Publié le 17/11/2026 à 17:45, il y a 6 heures 34 minutes EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP
Publié le 17/11/2026 à 07:40, il y a 16 heures 38 minutes SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.
Publié le 17/11/2026 à 23:40, il y a 39 minutes AI/ML Innovations Inc. Closes First Tranche of Private Placement
Publié le 17/11/2026 à 23:00, il y a 1 heure 19 minutes Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Publié le 17/11/2026 à 21:30, il y a 2 heures 49 minutes Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Publié le 17/11/2026 à 15:00, il y a 9 heures 19 minutes Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Publié le 17/11/2026 à 14:45, il y a 9 heures 34 minutes NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox (Monkeypox)
Publié le 17/11/2026 à 23:13, il y a 1 heure 5 minutes EQS-Adhoc: M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%
Publié le 17/11/2026 à 22:00, il y a 2 heures 19 minutes Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Publié le 17/11/2026 à 21:12, il y a 3 heures 7 minutes EQS-Adhoc: JDC Group AG: Adjustment of Full-Year Guidance
Publié le 17/11/2026 à 20:21, il y a 3 heures 58 minutes Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Publié le 17/11/2026 à 20:00, il y a 4 heures 19 minutes EQS-Adhoc: Sasol Financing USA LLC: SASOL ANNOUNCES RESULTS OF THE INVITATION TO REPURCHASE OUTSTANDING US$750 MILLION 4.5% GUARANTEED SENIOR UNSECURED CONVERTIBLE BONDS DUE 2027